Treatment regimes for patients over 65 with diabetes should be tailored to each patient to reduce the risk of hypoglycaemia, according to new US recommendations developed by the Endocrine Society.

The updated clinical practice guideline, containing 35 recommendations, was released at the Society’s conference in New Orleans, US, on Saturday and is due to be published in the Journal of Clinical Endocrinology & Metabolism in May.